The BareStory
Procter & Gamble reported financial results for the quarter ending December 31, posting sales of $22.21 billion, a 1% year-over-year increase that slightly missed analyst expectations. Adjusted earnings per share were $1.88, exceeding forecasts. While the company experienced a 1% overall decline in volume, this was offset by a 1% increase in pricing. Following the release, P&G shares rose in morning trading.
Performance varied significantly across the company’s portfolio and regions. The Beauty and Health Care segments posted organic sales growth of 4% and 3%, respectively. However, the Baby, Feminine & Family Care division saw a 4% decline in organic sales, driven by a 5% drop in volume. In North America, organic sales fell 2% during the fiscal second quarter. Conversely, international markets showed stronger momentum, with organic sales rising 8% in Latin America and 3% in Greater China.
In China, P&G is pursuing a strategy focused on premium innovation to counter demographic headwinds, following government data showing the birth rate fell to 5.6 per 1,000 people in 2025. The company launched "Pampers Prestige," a luxury diaper line utilizing silk fibers. CEO Shailesh Jejurikar stated that reframing the super-premium line has led to double-digit organic sales growth and increased market share for the baby care business in Greater China, contrasting with the segment's global struggles.
Executives characterized the recent period as the "softest" quarter of the fiscal year, attributing some U.S. weakness to delays in SNAP benefits and a government shutdown. The company maintained its full-year sales growth targets but revised its fiscal 2026 outlook for diluted net earnings per share growth down to a range of 1% to 6%, citing higher restructuring charges. During the quarter, P&G returned $4.8 billion to shareholders through dividends and share repurchases.
How it may affect me
As a U.S. reader:
You may encounter slightly higher prices for household goods, as the company offset a 1% decline in overall sales volume with a corresponding 1% increase in pricing.
Delays in SNAP benefits and the government shutdown were cited as causes for weak North American sales, highlighting how policy disruptions can impact consumer access to essential staples.
Investors and those with retirement portfolios may benefit from the company's financial strategies, as it returned $4.8 billion to shareholders and saw its stock price rise following the report.
You might notice diverging trends across product categories, with Beauty and Health Care segments growing while the Baby, Feminine & Family Care division experienced a significant drop in sales volume.
